Humira Kit
Product Images NDC 83457-817

Product Visual Gallery

This gallery contains 37 technical images submitted to the FDA as part of the official labeling for Humira (NDC 83457-817). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cordavis Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Study Ra-iii Acr 20 Responses Over 52 Weeks (Humira Cordavis Co Branded 01)

A line graph comparing the percent of ACR20 responders over time in weeks between a 40 mg every other week treatment and a placebo group. The y-axis shows percent ACR20 responders ranging from 0 to 70, and the x-axis shows time up to 48 weeks. The treatment group shows a higher and more sustained response compared to placebo.*

FDA Label Image

Figure 2. Asas 20 Response By Visit, Study As-i (Humira Cordavis Co Branded 02)

A line graph comparing the percentage of ASAS 20 response over time in weeks between Humira (Adalimumab) and placebo groups. The Humira group shows a higher and sustained response percentage across the 24-week period, while the placebo group shows a lower and less consistent response.*

FDA Label Image

Title: Km-graph-fig3-study-uv-i (Humira Cordavis Co Branded 03)

A line graph showing treatment failure rates over time (in months) comparing Humira and placebo groups. The y-axis represents treatment failure rate in percentage, and the x-axis represents time in months. Humira shows a lower failure rate compared to placebo throughout the study period.*

FDA Label Image

Title: Uveitis-km-fig3-part2 (Humira Cordavis Co Branded 04)

A line chart comparing treatment failure rates over 20 months for three groups: Humira, placebo, and an unspecified group (P80/111 and AO/115). The x-axis represents time in months, and the y-axis shows the treatment failure rate percentage.*

FDA Label Image

Title: Km-peds-uv (Humira Cordavis Co Branded 05)

A Kaplan-Meier survival curve graph displaying the probability of failing treatment over time in weeks. The graph compares two groups: one treated with Humira and the other with a placebo. The x-axis represents time (weeks), and the y-axis represents the probability of failing treatment, with corresponding participant counts displayed below the x-axis for each group at various time points.*

FDA Label Image

Title: Fig-a-ifu-40mg-pen (Humira Cordavis Co Branded 06)

An instructional diagram illustrating the components of the HUMIRA single-dose pen. It shows the pen disassembled with labeled parts including the gray cap #1, needle, white needle sleeve with white arrow, inspection window, plum activator button, and plum-colored cap #2.*

FDA Label Image

Title: Step1-pen-ifu-40mg (Humira Cordavis Co Branded 07)

An instructional illustration showing a hand reaching for a gray box from a shelf containing multiple bottles. This image is labeled as 'STEP 1' and appears to be part of a sequence for using or preparing the Humira (Adalimumab) kit by Cordavis Limited.*

FDA Label Image

Title: Ifu-40mg-0-4ml-pen-step2 (Humira Cordavis Co Branded 08)

An instructional illustration showing step 2 of a multi-step process for using a medical kit. The image depicts a sharps disposal container and a close-up of hands handling or preparing a disposable syringe or pen device. Several kit components including a pen injector, alcohol prep pad, and needle cap are shown arranged below the container.*

FDA Label Image

Title: Humira Mai Ifu Resize Step3 (Humira Cordavis Co Branded 09)

An instructional diagram labeled "STEP 3" showing recommended injectible areas for administration. The illustration highlights the abdomen area around the navel and the front of both thighs as suitable injection sites for the medication.*

FDA Label Image

Title: Humira Mai Ifu Resize1 Step4 (Humira Cordavis Co Branded 0a)

An instructional illustration showing Step 4 in using a medication pen. The image depicts a hand holding the pen, pressing it against the skin, with a zoomed-in view highlighting the injection area on the skin surface.*

FDA Label Image

Title: Humira-mai-ifu-resize1-step5 (Humira Cordavis Co Branded 0b)

An instructional diagram labeled Step 5 showing how to remove two caps from a device. An arrow points left to indicate removal of Cap #1, and two arrows point right toward Cap #2, indicating its removal. This is part of a kit for self-administration or preparation.*

FDA Label Image

Title: Ifu-40mg-0-4ml-pen-step6 (Humira Cordavis Co Branded 0c)

Instructional diagram labeled 'STEP 6' showing how to inject medication into the abdomen or thigh at a 90-degree angle. The illustration includes a side view of the injection sites on the body and hands positioning the injection device accordingly.*

FDA Label Image

Title: Humira Mai Ifu Resize1 Step7 (Humira Cordavis Co Branded 0d)

An instructional illustration labeled Step 7, showing hands holding a device with a yellow indicator. The image includes a clock icon with '10 seconds' and the text 'click,' indicating part of a timed step in using the device kit.*

FDA Label Image

Title: Humira Mai Ifu Resize1 Step8 (Humira Cordavis Co Branded 0e)

An instructional diagram labeled 'STEP 8' showing a close-up of hands using a medical device, with arrows indicating the correct motion or direction to follow during use, likely part of administration instructions for a HUMIRA (Adalimumab) kit.*

FDA Label Image

Title: Ifu-40mg0-4ml-pen-step9 (Humira Cordavis Co Branded 0f)

An instructional illustration labeled 'STEP 9' showing a hand holding a syringe or injector device positioned above or inserting into a rectangular container, likely a sharps disposal box or similar receptacle. The image depicts a disposal step for a drug administration kit.*

FDA Label Image

Title: Humira Mai Ifu Resize1 Calendar (Humira Cordavis Co Branded 10)

FDA Label Image

Title: Humira Mai Ifu Abbvie Logo (Humira Cordavis Co Branded 11)

FDA Label Image

Title: Step1-80mg-ifu (Humira Cordavis Co Branded 12)

An instructional illustration showing a hand reaching to pick up a rectangular object from a compartment, labeled as Step 1, indicating the beginning of a multi-step process in the use of the Humira (adalimumab) kit by Cordavis Limited.*

FDA Label Image

Title: 80mg-mai-ifu-step4 (Humira Cordavis Co Branded 13)

An instructional illustration labeled Step 4 showing a hand holding a pen-like device, with a close-up inset highlighting a detail on the device's upper section. The image appears to be part of a multi-step guide for using the Humira kit.*

FDA Label Image

Title: Ifu-80mg-0-8ml-pen-step6 (Humira Cordavis Co Branded 14)

An instructional illustration showing Step 6 for administering a medication, depicting an injection at a 90-degree angle into the abdomen or thigh. The diagram includes visual guidance for proper needle positioning relative to the skin surface.*

FDA Label Image

Title: 80mg-mai-ifu-step7-arrow (Humira Cordavis Co Branded 15)

An instructional illustration titled Step 7, showing a hand holding a device with an indicator window. The instruction emphasizes holding the device for 15 seconds until a "click" sound is heard, with a close-up highlighting the yellow indicator in the window.*

FDA Label Image

Title: 80mg-mai-ifu-logo (Humira Cordavis Co Branded 16)

FDA Label Image

Title: Fig-a-exploded-pfs (Humira Cordavis Co Branded 17)

Diagram labeled 'Figure A: HUMIRA Single-Dose Prefilled Syringe' showing a syringe with labeled parts: plunger, finger grip, and needle cover. The illustration highlights the main components of the Humira prefilled syringe kit by Cordavis Limited.*

FDA Label Image

Title: Ifu-single-dpse-pfs-step2 (Humira Cordavis Co Branded 18)

An instructional illustration labeled Step 2 related to the Humira kit. The image shows a disposal container and a hand using a syringe or injection device. Below, components from the kit such as a strip with an arrow, a small circular item, and a folded item are depicted, indicating preparation or disposal steps for the drug's administration process.*

FDA Label Image

Title: Syringe-pms-step3 (Humira Cordavis Co Branded 19)

An instructional illustration showing the injection areas for a medication, labeled as step 3. It highlights specific sites on the front thigh and the abdominal area around the navel as appropriate injection points. The image includes a close-up inset of the abdominal injection area.*

FDA Label Image

Title: Step4-pfs-ifu (Humira Cordavis Co Branded 1a)

An instructional illustration labeled 'STEP 4' showing a person holding a syringe with one hand while using the other hand to pull back the plunger, presumably preparing the injection. The image is part of a step-by-step guide.*

FDA Label Image

Title: Syringe-pms-step5 (Humira Cordavis Co Branded 1b)

An instructional illustration labeled 'STEP 5' showing a hand holding a syringe with a small needle poised above a vial or medication container, indicating preparation or administration of an injection.*

FDA Label Image

Title: Syringe-pms-step6 (Humira Cordavis Co Branded 1c)

Illustration showing Step 6 in a medication administration process within a kit, featuring a hand holding a syringe with the needle inserted into the skin, and a close-up inset of the injection site.*

FDA Label Image

Title: New-step-7-syringes (Humira Cordavis Co Branded 1d)

Illustration from Humira (adalimumab) kit instructions showing Step 7, which demonstrates the injection process with a marked injection site on the abdomen or thigh. The image guides users on proper injection placement on the body.*

FDA Label Image

Title: Step8-ifu-pfs (Humira Cordavis Co Branded 1e)

An instructional illustration labeled Step 8, showing a hand holding an injection device near a person's abdomen, demonstrating how to administer a subcutaneous injection as part of the Humira (Adalimumab) kit usage.*

FDA Label Image

Title: Ifu-single-dose-pfs-step9 (Humira Cordavis Co Branded 1f)

An instructional illustration labeled "STEP 9" showing a hand using a tool to perform an action on a rectangular container, likely part of a step-by-step guide related to the Humira Adalimumab kit.*

FDA Label Image

Title: Syringe-ifu-pms-abbvie-logo (Humira Cordavis Co Branded 20)

FDA Label Image

A Close-up Of A Packagedescription Automatically Generated (Humira Cordavis Co Branded 21)

Humira Pen adalimumab 40 mg/0.4 mL kit packaging label showing 2 single-dose prefilled pens. The label highlights 29 gauge needles and is for subcutaneous use only. Manufactured for Cordavis Limited, the label includes the AbbVie logo and website, with instructions and contents detailed.*

FDA Label Image

A Close-up Of A Prescription Medicinedescription Automatically Generated (Humira Cordavis Co Branded 22)

Humira Pen 80 mg/0.8 mL kit containing 2 single-dose prefilled pens of adalimumab for subcutaneous use. The label shows dosage strength, a 29 gauge needle size indication, and includes usage instructions. Manufactured for Cordavis Limited by AbbVie Inc., with U.S. license information and website humira.com. The packaging is primarily light blue with yellow and burgundy highlights.*

FDA Label Image

A Label Of A Medicinedescription Automatically Generated With Medium Confidence (Humira Cordavis Co Branded 23)

Humira 10 mg/0.1 mL kit packaging label containing 2 single-dose prefilled syringes of the active ingredient adalimumab for subcutaneous use. The label specifies a 29 gauge needle and includes manufacturer information for Cordavis Trading Limited, Dublin, Ireland, and AbbVie Inc., North Chicago, IL, USA. The carton details contents including alcohol prep pads, medication guide, package insert, and instructions for use.*

FDA Label Image

A Close-up Of A Labeldescription Automatically Generated (Humira Cordavis Co Branded 24)

Humira kit containing adalimumab 20 mg/0.2 mL in 2 single-dose prefilled syringes. The label highlights the 29 gauge needle and subcutaneous use only indication. Manufactured for Cordavis Trading Limited, Dublin, Ireland, and labeled by AbbVie Inc., North Chicago, USA. Includes medication guide and instructions for use.*

FDA Label Image

A Label Of A Medicinedescription Automatically Generated (Humira Cordavis Co Branded 25)

Humira (adalimumab) 40 mg/0.4 mL kit packaging label showing 2 single-dose prefilled syringes with 29 gauge needles for subcutaneous use. The label includes instructions for pharmacists and manufacturer information for Cordavis Limited. The packaging highlights the dosage strength and needle size.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.